HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hengmiao Cheng Selected Research
Hengmiao Cheng Research Topics
Disease
7
Neoplasms (Cancer)
01/2021 - 11/2011
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 11/2011
1
Hypersensitivity (Allergy)
01/2023
1
Sarcoma (Soft Tissue Sarcoma)
09/2018
1
Lung Neoplasms (Lung Cancer)
09/2018
1
Carcinogenesis
09/2012
1
Glaucoma
06/2009
1
Ocular Hypertension (Glaucoma, Suspect)
06/2009
1
Synovitis
03/2005
Drug/Important Bio-Agent (IBA)
3
Phosphotransferases (Kinase)
IBA
01/2021 - 01/2013
2
Phosphatidylinositols (Phosphatidylinositol)
IBA
01/2021 - 11/2011
2
ErbB Receptors (EGF Receptor)
IBA
09/2018 - 01/2017
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
03/2016 - 11/2011
2
Gefitinib (Iressa)
FDA Link
03/2016 - 11/2011
2
2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- one
IBA
01/2013 - 11/2011
1
Histamine (Histamine Dihydrochloride)
FDA Link
01/2023
1
TOR Serine-Threonine Kinases
IBA
01/2021
1
MTOR Inhibitors
IBA
03/2013
1
Ethanol (Ethyl Alcohol)
IBA
09/2012
1
Protein Kinase Inhibitors
IBA
09/2012
1
Proto-Oncogene Proteins c-met
IBA
09/2012
1
Proteins (Proteins, Gene)
FDA Link
11/2011
1
Carbenoxolone
IBA
06/2009
1
11-beta-Hydroxysteroid Dehydrogenase Type 1
IBA
06/2009
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
06/2009
1
Steroids
IBA
06/2009
1
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
03/2005
Therapy/Procedure
1
Therapeutics
11/2011